🌎 Geron Downgraded, Koninklijke Philips Upgraded, PVH Initiated and more…
RJ Hamster
Advertisements
Ratings changes for SoFi Technologies, SoFi Technologies, Jaguar Health, Marin Software, Zillow Group, Iteris, Intuit and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
A titan of the aerospace industry announced it would no longer purchase titanium from Russia, a key supplier. With a global shortage of the lightweight “wonder metal” already in play, aerospace-grade titanium has become particularly scarce.
Alphabet (NASDAQ:GOOGL) had its price target raised by analysts at Argus () from $170.00 to $200.00. They now have a “buy” rating on the stock. This represents a 20.9% upside from the current price of $165.42.
Citizens Financial Services (NASDAQ:CZFS) was upgraded by analysts at Janney Montgomery Scott from a “neutral” rating to a “buy” rating. They now have a $53.00 price target on the stock. This represents a 29.0% upside from the current price of $41.09.
Deciphera Pharmaceuticals (NASDAQ:DCPH) was upgraded by analysts at Barclays PLC from an “underweight” rating to an “equal weight” rating. They now have a $26.00 price target on the stock, up previously from $9.00. This represents a 2.6% upside from the current price of $25.33.
Hope Bancorp (NASDAQ:HOPE) was upgraded by analysts at DA Davidson from a “neutral” rating to a “buy” rating. They now have a $12.50 price target on the stock. This represents a 24.5% upside from the current price of $10.04.
MSCI (NYSE:MSCI) was upgraded by analysts at Bank of America Co. from an “underperform” rating to a “neutral” rating. They now have a $525.00 price target on the stock, up previously from $425.00. This represents a 11.2% upside from the current price of $472.00.
Koninklijke Philips (NYSE:PHG) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating.The current price is $26.98.
Koninklijke Philips (NYSE:PHG) was upgraded by analysts at UBS Group AG from a “sell” rating to a “neutral” rating.The current price is $26.98.
UMB Financial (NASDAQ:UMBF) was upgraded by analysts at Barclays PLC from an “equal weight” rating to an “overweight” rating. They now have a $95.00 price target on the stock, up previously from $91.00. This represents a 18.9% upside from the current price of $79.93.
Boeing (NYSE:BA) was downgraded by analysts at Argus from a “buy” rating to a “hold” rating.The current price is $172.33.
Chegg (NYSE:CHGG) was downgraded by analysts at Jefferies Financial Group Inc. from a “hold” rating to an “underperform” rating. They now have a $4.00 price target on the stock, down previously from $7.00. This represents a 25.5% downside from the current price of $5.37.
Geron (NASDAQ:GERN) was downgraded by analysts at Robert W. Baird from an “outperform” rating to a “neutral” rating. They now have a $4.50 price target on the stock. This represents a 13.1% upside from the current price of $3.98.
Paramount Global (NASDAQ:PARA) was downgraded by analysts at Needham & Company LLC from a “buy” rating to a “hold” rating.The current price is $11.74.
XP (NASDAQ:XP) was downgraded by analysts at The Goldman Sachs Group, Inc. from a “buy” rating to a “neutral” rating. They now have a $23.00 price target on the stock, down previously from $30.00. This represents a 7.4% upside from the current price of $21.42.
Adverum Biotechnologies (NASDAQ:ADVM) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $30.00 price target on the stock. This represents a 201.2% upside from the current price of $9.96.
ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at HC Wainwright. They set a “buy” rating and a $25.00 price target on the stock. This represents a 51.5% upside from the current price of $16.50.
Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $29.00 price target on the stock. This represents a 82.6% upside from the current price of $15.88.
Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $25.00 price target on the stock. This represents a 57.4% upside from the current price of $15.88.
Contineum Therapeutics (NASDAQ:CTNM) is now covered by analysts at Royal Bank of Canada. They set an “outperform” rating and a $30.00 price target on the stock. This represents a 88.9% upside from the current price of $15.88.
Precision BioSciences (NASDAQ:DTIL) is now covered by analysts at Guggenheim. They set a “buy” rating and a $19.00 price target on the stock. This represents a 85.0% upside from the current price of $10.27.
Dyne Therapeutics (NASDAQ:DYN) is now covered by analysts at Morgan Stanley. They set an “overweight” rating and a $40.00 price target on the stock. This represents a 58.8% upside from the current price of $25.19.
Excelerate Energy (NYSE:EE) is now covered by analysts at Stephens. They set an “overweight” rating and a $21.00 price target on the stock. This represents a 24.0% upside from the current price of $16.94.
Integral Ad Science (NASDAQ:IAS) is now covered by analysts at Loop Capital. They set a “buy” rating and a $15.00 price target on the stock. This represents a 55.9% upside from the current price of $9.62.
Immunome (NASDAQ:IMNM) is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $24.00 price target on the stock. This represents a 70.5% upside from the current price of $14.08.
Iteris (NASDAQ:ITI) is now covered by analysts at Maxim Group. They set a “buy” rating and a $11.00 price target on the stock. This represents a 147.7% upside from the current price of $4.44.
Lexicon Pharmaceuticals (NASDAQ:LXRX) is now covered by analysts at SVB Leerink LLC. They set an “outperform” rating and a $5.00 price target on the stock. This represents a 224.7% upside from the current price of $1.54.
Live Nation Entertainment (NYSE:LYV) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “buy” rating and a $120.00 price target on the stock. This represents a 34.7% upside from the current price of $89.06.
MINISO Group (NYSE:MNSO) is now covered by analysts at JPMorgan Chase & Co.. They set an “overweight” rating and a $30.00 price target on the stock. This represents a 31.6% upside from the current price of $22.80.
Marker Therapeutics (NASDAQ:MRKR) is now covered by analysts at LADENBURG THALM/SH SH. They set a “buy” rating and a $11.00 price target on the stock. This represents a 158.8% upside from the current price of $4.25.
Ovid Therapeutics (NASDAQ:OVID) is now covered by analysts at B. Riley. They set a “buy” rating and a $9.00 price target on the stock. This represents a 183.9% upside from the current price of $3.17.
Personalis (NASDAQ:PSNL) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $4.00 price target on the stock. This represents a 169.4% upside from the current price of $1.49.
PVH (NYSE:PVH) is now covered by analysts at Jefferies Financial Group Inc.. They set a “hold” rating and a $115.00 price target on the stock. This represents a 4.3% upside from the current price of $110.28.
Ralph Lauren (NYSE:RL) is now covered by analysts at Jefferies Financial Group Inc.. They set a “buy” rating and a $195.00 price target on the stock. This represents a 18.0% upside from the current price of $165.29.
Red Robin Gourmet Burgers (NASDAQ:RRGB) is now covered by analysts at Lake Street Capital. They set a “buy” rating and a $16.00 price target on the stock. This represents a 112.2% upside from the current price of $7.54.
Telesat (NASDAQ:TSAT) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a “hold” rating and a $9.00 price target on the stock. This represents a 23.8% upside from the current price of $7.27.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.
UPGRADE NOW
Manage Your Watchlist
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO
Join Our Facebook Group
Join MarketBeat’s free stock discussion and trading idea group on Facebook.
JOIN NOW
Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that’s you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
